The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity
- PMID: 21856009
- PMCID: PMC3223548
- DOI: 10.1016/j.ophtha.2011.05.013
The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity
Abstract
Objective: The purpose of the study was to examine (1) how patient adherence and eye drop technique were associated with visual field defect severity and (2) how general glaucoma adherence self-efficacy and eye drop technique self-efficacy were related to visual field defect severity.
Design: Cross-sectional study conducted at a single private practice site.
Participants: Patients using eye drops for their glaucoma.
Methods: Subject adherence to glaucoma medications through Medication Events Monitoring System (MEMS) devices were measured, and eye drop instillation technique was assessed by video recording. General glaucoma medication adherence self-efficacy was measured using a 10-item scale, and eye drop technique self-efficacy was measured using a 6-item scale. Multivariate logistic regression was used to analyze the data.
Main outcome measures: Visual field defect severity.
Results: Patients who were less than 80% adherent according to the MEMS devices were significantly more likely to have worse defect severity. Patients with lower scores on the general glaucoma medication adherence self-efficacy scale also were significantly more likely to have worse defect severity. Eye drop technique and eye drop technique self-efficacy were not related significantly to visual field defect severity.
Conclusions: Eye care providers need to assess patient adherence and to work with those patients with poor adherence to find ways to improve their ability and self-efficacy in using their glaucoma medications.
Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
No conflict of author exists for any author.
Similar articles
-
Validation of a short version of the glaucoma medication self-efficacy questionnaire.Br J Ophthalmol. 2012 Feb;96(2):258-62. doi: 10.1136/bjo.2010.199851. Epub 2011 May 24. Br J Ophthalmol. 2012. PMID: 21610264
-
A video study of drop instillation in both glaucoma and retina patients with visual impairment.Am J Ophthalmol. 2011 Dec;152(6):982-8. doi: 10.1016/j.ajo.2011.05.015. Epub 2011 Aug 6. Am J Ophthalmol. 2011. PMID: 21821228
-
Drop instillation and glaucoma.Curr Opin Ophthalmol. 2018 Mar;29(2):171-177. doi: 10.1097/ICU.0000000000000451. Curr Opin Ophthalmol. 2018. PMID: 29140818 Free PMC article. Review.
-
The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success.J Glaucoma. 2019 Mar;28(3):e46-e48. doi: 10.1097/IJG.0000000000001136. J Glaucoma. 2019. PMID: 30822299
-
A comprehensive perspective on patient adherence to topical glaucoma therapy.Ophthalmology. 2009 Nov;116(11 Suppl):S30-6. doi: 10.1016/j.ophtha.2009.06.024. Ophthalmology. 2009. PMID: 19837258 Review.
Cited by
-
ChatGPT: is it good for our glaucoma patients?Front Ophthalmol (Lausanne). 2023 Nov 16;3:1260415. doi: 10.3389/fopht.2023.1260415. eCollection 2023. Front Ophthalmol (Lausanne). 2023. PMID: 38983063 Free PMC article.
-
Investigation of visual and physical factors associated with inadequate instillation of eyedrops among patients with glaucoma.PLoS One. 2021 May 14;16(5):e0251699. doi: 10.1371/journal.pone.0251699. eCollection 2021. PLoS One. 2021. PMID: 33989342 Free PMC article. Clinical Trial.
-
Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension.Drugs. 2024 Jan;84(1):83-97. doi: 10.1007/s40265-023-01973-7. Epub 2023 Dec 7. Drugs. 2024. PMID: 38060092 Free PMC article. Clinical Trial.
-
Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension.Ophthalmol Ther. 2022 Aug;11(4):1517-1537. doi: 10.1007/s40123-022-00527-6. Epub 2022 May 28. Ophthalmol Ther. 2022. PMID: 35643967 Free PMC article.
-
Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma.Am J Ophthalmol. 2022 Dec;244:216-227. doi: 10.1016/j.ajo.2022.08.011. Epub 2022 Aug 21. Am J Ophthalmol. 2022. PMID: 36002073 Free PMC article. Clinical Trial.
References
-
- Spaeth GL. Visual loss in a glaucoma clinic. I. Sociological considerations. Invest Ophthalmol. 1970;9:73–82. - PubMed
-
- Kass MA, Hodapp E, Gordon M, et al. Part I. Patient administration of eyedrops: interview. Ann Ophthalmol. 1982;14:775–779. - PubMed
-
- Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically: the Travatan Dosing Aid study. Ophthalmology. 2009;116:191–199. - PubMed
-
- Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: state of the science and directions for observational research. Am J Ophthalmol. 2010;150:569–574. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical